HIV Citations List: June, 2016

Literature Citations

1. Curcumin Inhibits HIV-1 by Promoting Tat Protein Degradation. Ali, A. and A.C. Banerjea. Scientific Reports, 2016. 6(27539): 9pp. PMID[27283735]. PMCID [PMC4901322].

[PubMed]. HIV_06_2016.

2. Synthesis, Anti-inflammatory, Bactericidal Activities and Docking Studies of Novel 1,2,3-Triazoles Derived from Ibuprofen Using Click Chemistry. Angajala, K.K., S. Vianala, R. Macha, M. Raghavender, M.K. Thupurani, and P.J. Pathi. SpringerPlus, 2016. 5(423): 15pp. PMID[27104111]. PMCID[PMC4828371].

[PubMed]. HIV_06_2016.

3. Microwave Assisted Synthesis of (E)-1-(2-((1-Benzyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-3-(9-ethyl-9H-carbazol-3-yl)prop-2-en-1-ones and Their Antimicrobial Activity. Ashok, D., S. Ravi, B.V. Lakshmi, A. Ganesh, and S. Adam. Russian Journal of Bioorganic Chemistry, 2016. 42(3): p. 323-331. ISI[000377595200011].

[WOS]. HIV_06_2016.

4. 2-Hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as Human Immunodeficiency Virus Type 1 Integrase Inhibitors: Influence of the Alkylcarboxamide Substitution of Position 4.Billamboz, M., V. Suchaud, F. Bailly, C. Lion, M.-L. Andreola, F. Christ, Z. Debyser, and P. Cotelle. European Journal of Medicinal Chemistry, 2016. 117: p. 256-268. PMID[27105029].

[PubMed]. HIV_06_2016.

5. Bispecific anti-HIV-1 Antibodies with Enhanced Breadth and Potency.Bournazos, S., A. Gazumyan, M.S. Seaman, M.C. Nussenzweig, and J.V. Ravetch. Cell, 2016. 165(7): p. 1609-1620. PMID[27315478].

[PubMed]. HIV_06_2016.

6. Synthesis and Properties of Hemostatic and Bacteria-Responsive In Situ Hydrogels for Emergency Treatment in Critical Situations. Bu, Y., L. Zhang, J. Liu, L. Zhang, T. Li, H. Shen, X. Wang, F. Yang, P. Tang, and D. Wu. ACSApplied Materials & Interfaces, 2016. 8(20): p. 12674-12683. PMID[ 27159886].

[PubMed]. HIV_06_2016.

7. HIV Capsid Assembly, Mechanism, and Structure. Chen, B. Biochemistry, 2016. 55(18): p. 2539-2552. PMID[27074418].

[PubMed]. HIV_06_2016.

8. Design, Synthesis and anti-HIV-Reverse Transcriptase Activity of Novel Diaryl Thiazolindin-4-one Derivatives Possessing Amide Linkage on N-3 Position. Chen Hua, Shao Jie, Zhu Mo, and Li Xiaoliu. Chinese Journal of Organic Chemistry, 2016. 36(3): p. 527-532. ISI[000375637600009].

[WOS]. HIV_06_2016.

9. Synthesis and Bioevaluation of Substituted Chalcones, Coumaranones and Other Flavonoids as anti-HIV Agents.Cole, A.L., S. Hossain, A.M. Cole, and O.t. Phanstiel. Bioorganic & Medicinal Chemistry, 2016. 24(12): p. 2768-2776. PMID[27161874].

[PubMed]. HIV_06_2016.

10. Identification of Vimentin as a Potential Therapeutic Target against HIV Infection.Fernandez-Ortega, C., A. Ramirez, D. Casillas, T. Paneque, R. Ubieta, M. Dubed, L. Navea, L. Castellanos-Serra, C. Duarte, V. Falcon, O. Reyes, H. Garay, E. Silva, E. Noa, Y. Ramos, V. Besada, and L. Betancourt. Viruses, 2016. 8(98): 19pp. PMID[27314381].

[PubMed]. HIV_06_2016.

11. Gold(I) Complex of 1,1'-bis(Diphenylphosphino) Ferrocene-quinoline Conjugate: A Virostatic Agent against HIV-1.Gama, N., K. Kumar, E. Ekengard, M. Haukka, J. Darkwa, E. Nordlander, and D. Meyer. Biometals, 2016. 29(3): p. 389-397. PMID[26922346].

[PubMed]. HIV_06_2016.

12. Definition of an 18-Mer Synthetic Peptide Derived from the GB Virus C E1 Protein as a New HIV-1 Entry Inhibitor.Gomara, M.J., V. Sanchez-Merino, A. Paus, A. Merino-Mansilla, J.M. Gatell, E. Yuste, and I. Haro. Biochimica et Biophysica Acta, 2016. 1860(6): p. 1139-1148. PMID[26905802].

[PubMed]. HIV_06_2016.

13. Systematic Evaluation of Methyl Ester Bioisosteres in the Context of Developing Alkenyldiarylmethanes (ADAMs) as Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) for anti-HIV-1 Chemotherapy. Hoshi, A., T. Sakamoto, J. Takayama, M. Xuan, M. Okazaki, T.L. Hartman, R.W. Buckheit, Jr., C. Pannecouque, and M. Cushman. Bioorganic & Medicinal Chemistry, 2016. 24(13): p. 3006-3022. PMID[27234889].

[PubMed]. HIV_06_2016.

14. Synthesis of Seven-membered Iminosugars Fused Thiazolidin-4-one and Benzthiazinan-4-one and Their HIV-RT Inhibitory Activity. Hou, Y., S. Xing, J. Shao, Z. Yin, L. Hao, T. Yang, H. Zhang, M. Zhu, H. Chen, and X. Li. Carbohydrate Research, 2016. 429: p. 105-112. PMID[27017974].

[PubMed]. HIV_06_2016.

15. Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity. Huang, Y., J. Yu, A. Lanzi, X. Yao, C.D. Andrews, L. Tsai, M.R. Gajjar, M. Sun, M.S. Seaman, N.N. Padte, and D.D. Ho. Cell, 2016. 165(7): p. 1621-1631. PMID[27315479].

[PubMed]. HIV_06_2016.

16. Design and Discovery of Novel Thiazole Acetamide Derivatives as anti-HIV Agent Towards AIDS Treatment via Inhibition of Reverse Transcriptase.Jiang, Y.-K., X.-Y. Zhang, and W.-M. Jiang. Latin American Journal of Pharmacy, 2016. 35(3): p. 537-544. ISI[000375968200016].

[WOS]. HIV_06_2016.

17. New Approach for Inhibition of HIV Entry: Modifying CD4 Binding Sites by Thiolated Pyrimidine Derivatives.Kanizsai, S., J. Ongradi, J. Aradi, and K. Nagy. Pathology & Oncology Research, 2016. 22(3): p. 617-623. PMID[26860867].

[PubMed]. HIV_06_2016.

18. Expression of HIV-encoded microRNA-Tar and Its Inhibitory Effect on Viral Replication in Human Primary Macrophages. Li, L., H. Feng, Q. Da, H. Jiang, L. Chen, L. Xie, Q. Huang, H. Xiong, F. Luo, L. Kang, Y. Zeng, H. Hu, W. Hou, and Y. Feng. Archives of Virology, 2016. 161(5): p. 1115-1123. PMID[26831929].

[PubMed]. HIV_06_2016.

19. Design, Synthesis and Activity Screening of Isopeptide Bond-tethered N Peptides as HIV-1 Fusion Inhibitors. Li Xue, Lai Wenqing, Jiang Xifeng, Wang Chao, and Liu Keliang. Chemical Journal of Chinese Universities, 2016. 37(5): p. 881-885. ISI[000376482400012].

[WOS]. HIV_06_2016.

20. Synthesis and Biological Evaluation of Phenylpropanoid Derivatives.Liu, S., Y. Li, W. Wei, and J. Wei. Medicinal Chemistry Research, 2016. 25(6): p. 1074-1086. ISI[000375563900004].

[WOS]. HIV_06_2016.

21. Identification and Characterization of BMS-955176, a Second-generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage.Nowicka-Sans, B., T. Protack, Z. Lin, Z. Li, S. Zhang, Y. Sun, H. Samanta, B. Terry, Z. Liu, Y. Chen, N. Sin, S.Y. Sit, J.J. Swidorski, J. Chen, B.L. Venables, M. Healy, N.A. Meanwell, M. Cockett, U. Hanumegowda, A. Regueiro-Ren, M. Krystal, and I.B. Dicker. Antimicrobial Agents and Chemotherapy, 2016. 60(7): p. 3956-3969. PMID[27090171]. PMCID[PMC4914680].

[PubMed]. HIV_06_2016.

22. Pharmacokinetic and Pharmacodynamic Evaluation Following Vaginal Application of IQB3002, a Dual-chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques. Pereira, L.E., P.M.M. Mesquita, A. Ham, T. Singletary, F. Deyounks, A. Martin, J. McNicholl, K.W. Buckheit, R.W. Buckheit, Jr., and J.M. Smith. Antimicrobial Agents and Chemotherapy, 2016. 60(3): p. 1393-1400. PMID[26666935]. PMCID[PMC4775942].

[PubMed]. HIV_06_2016.

23. Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity.Regueiro-Ren, A., Z. Liu, Y. Chen, N. Sin, S.Y. Sit, J.J. Swidorski, J. Chen, B.L. Venables, J. Zhu, B. Nowicka-Sans, T. Protack, Z. Lin, B. Terry, H. Samanta, S. Zhang, Z. Li, B.R. Beno, X.S. Huang, S. Rahematpura, D.D. Parker, R. Haskell, S. Jenkins, K.S. Santone, M.I. Cockett, M. Krystal, N.A. Meanwell, U. Hanumegowda, and I.B. Dicker. ACS Medicinal Chemistry Letters, 2016. 7(6): p. 568-572. PMID[27326328]. PMCID[PMC4904268].

[PubMed]. HIV_06_2016.

24. Development and Identification of a Novel anti-HIV-1 Peptide Derived by Modification of the N-terminal Domain of HIV-1 Integrase.Sala, M., A. Spensiero, F. Esposito, M.C. Scala, E. Vernieri, A. Bertamino, M. Manfra, A. Carotenuto, P. Grieco, E. Novellino, M. Cadeddu, E. Tramontano, D. Schols, P. Campiglia, and I.M. Gomez-Monterrey. Frontiers in Microbiology, 2016. 7(845): 9pp. ISI[000377597200001].

[WOS]. HIV_06_2016.

25. Remarkable in Vitro anti-HIV Activity of New Silver(I)- and Gold(I)-n-heterocyclic Carbene Complexes. Synthesis, DNA Binding and Biological Evaluation.Sanchez, O., S. Gonzalez, A.R. Higuera-Padilla, Y. Leon, D. Coll, M. Fernandez, P. Taylor, I. Urdanibia, H.R. Rangel, J.T. Ortega, W. Castro, and M. Cristina Goite. Polyhedron, 2016. 110: p. 14-23. ISI[000375518900002].

[WOS]. HIV_06_2016.

26. Synthesis, Molecular Docking and alpha-Glucosidase Inhibition of 5-Aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-Oxadiazoles.Taha, M., N.H. Ismail, S. Imran, A. Wadood, F. Rahim, S.M. Saad, K.M. Khan, and A. Nasir. Bioorganic Chemistry, 2016. 66: p. 117-123. PMID[27149363].

[PubMed]. HIV_06_2016.

27. Synthesis, and Prediction of Molecular Properties and Antimicrobial Activity of Some Acylhydrazones Derived from N-(Arylsulfonyl)methionine.Tatar, E., S. Senkardes, H.E. Sellitepe, S.G. Kucukguzel, S.A. Karaoglu, A. Bozdeveci, E. De Clercq, C. Pannecouque, T. Ben Hadda, and I. Kucukguzel. Turkish Journal of Chemistry, 2016. 40(3): p. 510-534. ISI[000376305300013].

[WOS]. HIV_06_2016.

28. Ebselen, a Small-molecule Capsid Inhibitor of HIV-1 Replication.Thenin-Houssier, S., I.M.S. de Vera, L. Pedro-Rosa, A. Brady, A. Richard, B. Konnick, S. Opp, C. Buffone, J. Fuhrmann, S. Kota, B. Billack, M. Pietka-Ottlik, T. Tellinghuisen, H. Choe, T. Spicer, L. Scampavia, F. Diaz-Griffero, D.J. Kojetin, and S.T. Valente. Antimicrobial Agents and Chemotherapy, 2016. 60(4): p. 2195-2208. PMID[26810656]. PMCID[PMC4808204].

[PubMed]. HIV_06_2016.

29. Identification of Potent Maturation Inhibitors against HIV-1 Clade C.Timilsina, U., D. Ghimire, B. Timalsina, T.J. Nitz, C.T. Wild, E.O. Freed, and R. Gaur. Scientific Reports, 2016. 6(27403): 6pp. PMID[27264714]. PMCID[PMC4893694].

[PubMed]. HIV_06_2016.

30. Progress and Prospects on DENV Protease Inhibitors. Timiri, A.K., B.N. Sinha, and V. Jayaprakash. European Journal of Medicinal Chemistry, 2016. 117: p. 125-143. PMID[27092412].

[PubMed]. HIV_06_2016.

31. Thiazolides Elicit Anti-viral Innate Immunity and Reduce HIV Replication. Trabattoni, D., F. Gnudi, S.V. Ibba, I. Saulle, S. Agostini, M. Masetti, M. Biasin, J.F. Rossignol, and M. Clerici. Scientific Reports, 2016. 6(27148): 10pp. PMID[27250526]. PMCID[PMC4890011].

[PubMed]. HIV_06_2016.

32. Cyanovirin-N Produced in Rice Endosperm Offers Effective Pre-exposure Prophylaxis against HIV-1(BaL) Infection In Vitro. Vamvaka, E., A. Evans, K. Ramessar, L.R.H. Krumpe, R.J. Shattock, B.R. O'Keefe, P. Christou, and T. Capell. Plant Cell Reports, 2016. 35(6): p. 1309-1319. PMID[27007716].

[PubMed]. HIV_06_2016.

33. Nonhuman Primate IFITM Proteins are Potent Inhibitors of HIV and SIV. Wilkins, J., Y.M. Zheng, J. Yu, C. Liang, and S.L. Liu. Plos One, 2016. 11(6): p. e0156739. PMID[27257969]. PMCID[PMC4892622].

[PubMed]. HIV_06_2016.

34. A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity. Woodrum, B.W., J. Maxwell, D.M. Allen, J. Wilson, L.R. Krumpe, A.A. Bobkov, R.B. Hill, K.V. Kibler, B.R. O'Keefe, and G. Ghirlanda. Viruses, 2016. 8(6): 15pp. PMID[27275831].

[PubMed]. HIV_06_2016.

35. Development of Novel Proteasome Inhibitors Based on Phthalazinone Scaffold. Yang, L., W. Wang, Q. Sun, F. Xu, Y. Niu, C. Wang, L. Liang, and P. Xu. Bioorganic & Medicinal Chemistry Letters, 2016. 26(12): p. 2801-2805. PMID[27158142].

[PubMed]. HIV_06_2016.

36. Application of Ligand- and Receptor-based Approaches for Prediction of the HIV-RT Inhibitory Activity of Fullerene Derivatives. Yilmaz, H., L. Ahmed, B. Rasulev, and J. Leszczynski. Journal of Nanoparticle Research, 2016. 18(123): 12pp. ISI[000375621800001].

[WOS]. HIV_06_2016.

37. Small Molecule ONC201/TIC10 Inhibits HIV-1 Replication and Integration.Zhao, R., B. Wu, Y. Huang, and J.C. Zheng. Journal of Neuroimmune Pharmacology, 2016. 11: p. S52-S52. ISI[000377566000134].

[WOS]. HIV_06_2016.

38. HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases. Zhao, X.Z., S.J. Smith, D.P. Maskell, M. Metifiot, V.E. Pye, K. Fesen, C. Marchand, Y. Pommier, P. Cherepanov, S.H. Hughes, and T.R. Burke, Jr. ACS Chemical Biology, 2016. 11(4): p. 1074-1081. PMID[26808478]. PMCID[PMC4836387].

[PubMed]. HIV_06_2016.

Patent Citations

39. Novel Cyclic Peptides and Methods Using Same. Chaiken, I.M. and A.A.R. Ahmed. Patent. 2016. 2015-US64708 2016094518: 84pp.

[Patent]. HIV_06_2016.

40. Preparation of Spirocyclic Heterocycle Compounds Useful as HIV Integrase Inhibitors. Embrey, M.W., T.H. Graham, I.T. Raheem, J.D. Schreier, S.T. Waddell, L. Hu, X. Peng, and J.S. Wai. Patent. 2016. 2014-CN93335 2016090545: 75pp.

[Patent]. HIV_06_2016.

41. Preparation of Spirocyclic Heterocycle Compounds Useful as HIV Integrase Inhibitors. Embrey, M.W., T.H. Graham, I.T. Raheem, J.D. Schreier, S.T. Waddell, J.S. Wai, L. Hu, and X. Peng. Patent. 2016. 2015-US63850 2016094197: 96pp.

[Patent]. HIV_06_2016.

42. Preparation of Spirocyclic Heterocycle Compounds Useful as HIV Integrase Inhibitors. Graham, T.H., M.W. Embrey, A. Walji, and S.T. Waddell. Patent. 2016. 2015-US63851 2016094198: 68pp.

[Patent]. HIV_06_2016.

43. Preparation of Triazole Derivatives as anti-AIDS Agents. Lu, S., H. Zhang, J. Yu, C. Shi, and X. Yu. Patent. 2016. 2015-CN75463 2016082403: 20pp ; Chemical Indexing Equivalent to 162:425301 (CN).

[Patent]. HIV_06_2016.

44. Use of Tetrahydroindazolylbenzamide and Tetrahydroindolylbenzamide Derivatives for the Treatment of Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS). Orlemans, E.O.M., B.F. Haynes, G. Ferrari, T. Haystead, and J.J. Kwiek. Patent. 2016. 2015-14952421 20160143884: 62pp.

[Patent]. HIV_06_2016.

45. Preparation of Oxolupene Derivatives and Use as anti-HIV Agents. Regueiro-Ren, A., Z. Liu, J. Swidorski, and N.A. Meanwell. Patent. 2016. 2015-US60344 2016077561: 130pp.

[Patent]. HIV_06_2016.